385 related articles for article (PubMed ID: 31382568)
1. Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS.
Apolloni S; Caputi F; Pignataro A; Amadio S; Fabbrizio P; Ammassari-Teule M; Volonté C
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382568
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in the inflammatory and heat shock response in glia: implications for ALS.
Clarke BE; Gil RS; Yip J; Kalmar B; Greensmith L
Cell Stress Chaperones; 2019 Sep; 24(5):857-870. PubMed ID: 31168740
[TBL] [Abstract][Full Text] [Related]
3. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
[TBL] [Abstract][Full Text] [Related]
4. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
5. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
6. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
7. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
8. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
9. Perineuronal nets are phagocytosed by MMP-9 expressing microglia and astrocytes in the SOD1
Cheung SW; Bhavnani E; Simmons DG; Bellingham MC; Noakes PG
Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12982. PubMed ID: 38742276
[TBL] [Abstract][Full Text] [Related]
10. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
[TBL] [Abstract][Full Text] [Related]
12. Regional Differences in Heat Shock Protein 25 Expression in Brain and Spinal Cord Astrocytes of Wild-Type and SOD1
San Gil R; Clarke BE; Ecroyd H; Kalmar B; Greensmith L
Cells; 2021 May; 10(5):. PubMed ID: 34069691
[TBL] [Abstract][Full Text] [Related]
13. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
[TBL] [Abstract][Full Text] [Related]
14. Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model.
Anzilotti S; Valsecchi V; Brancaccio P; Guida N; Laudati G; Tedeschi V; Petrozziello T; Frecentese F; Magli E; Hassler B; Cuomo O; Formisano L; Secondo A; Annunziato L; Pignataro G
Neurobiol Dis; 2021 Nov; 159():105480. PubMed ID: 34411705
[TBL] [Abstract][Full Text] [Related]
15. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Petri S; Chen J; Calingasan NY; Beal MF
Neurodegener Dis; 2005; 2(5):246-54. PubMed ID: 16909005
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the multiple roles of FGF-2 in SOD1
Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S
J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
Seredenina T; Nayernia Z; Sorce S; Maghzal GJ; Filippova A; Ling SC; Basset O; Plastre O; Daali Y; Rushing EJ; Giordana MT; Cleveland DW; Aguzzi A; Stocker R; Krause KH; Jaquet V
Free Radic Biol Med; 2016 Aug; 97():95-108. PubMed ID: 27212019
[TBL] [Abstract][Full Text] [Related]
19. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
20. Histaminergic transmission slows progression of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Fabbrizio P; Morello G; Spampinato AG; Latagliata EC; Salvatori I; Proietti D; Ferri A; Madaro L; Puglisi-Allegra S; Cavallaro S; Volonté C
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):872-893. PubMed ID: 31020811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
